EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Detection of anti-drug antibodies during monoclonal antibody drug therapy

Frans Kokojka, Denis Mulleman, Robert S Marks

Trends in Biotechnology · 2026-05

DOI: 10.1016/j.tibtech.2026.04.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Biotechnology, 2026-05. Verfasst von Frans Kokojka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology Engineering, Faculty of Engineering Science, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel. Electronic a…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: The Leona M and Harry B Helmsley Charitable Trust, Israel Innovation Authority.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic monoclonal antibodies can elicit anti-drug antibodies (ADAs) in patients, which impact drug pharmacokinetics, reduce efficacy, and occasionally cause hypersensitivity reactions. Growing evidence indicates that early detection of ADA responses improves therapy outcomes, yet their monitoring has remained underappreciated. Conventional assays are complex, time-consuming, and confined to centralized laboratories, thereby delaying clinical decisions. In contrast, emerging biosensor technologies represent a promising alternative for timely, on-site ADA detection. This review examines advancements in ADA detection and provides a critical overview of its clinical relevance based on contemporary findings. Furthermore, the challenges and complexities of accurately biosensing ADAs are discussed. Finally, we explore the prospects of biosensors for on-site analysis and their integration into proactive therapeutic drug monitoring.

Schlagwörter

Stichwörter der Autor:innen

anti-drug antibodiesbiosensorsimmunogenicityimmunotherapymAb

Autor:innen und Institutionen

  • Department of Biotechnology Engineering, Faculty of Engineering Science, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel. Electronic address: fransk@post.bgu.ac.il.
  • Nanomedicines and Nanoprobes Department, Center for Molecular Biophysics, UPR CNRS 4301, University of Tours, Tours, France.
  • Department of Biotechnology Engineering, Faculty of Engineering Science, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel. Electronic address: rsmarks@bgu.ac.il.

Förderung

  • The Leona M and Harry B Helmsley Charitable Trust
  • Israel Innovation Authority

Zitieren

APA

Kokojka, F., Mulleman, D., & Marks, R. S. (2026). Detection of anti-drug antibodies during monoclonal antibody drug therapy. Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2026.04.003

Vancouver

Kokojka F, Mulleman D, Marks RS. Detection of anti-drug antibodies during monoclonal antibody drug therapy. Trends in Biotechnology. 2026. doi:10.1016/j.tibtech.2026.04.003

BibTeX
@article{Kokojka2026,
  author = {Kokojka, Frans and Mulleman, Denis and Marks, Robert S},
  title = {Detection of anti-drug antibodies during monoclonal antibody drug therapy},
  journal = {Trends in Biotechnology},
  year = {2026},
  doi = {10.1016/j.tibtech.2026.04.003}
}
Kostenlos starten →